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Background: The Current Opioid Misuse Measure (COMM) is a self-report questionnaire designed to help identify
aberrant drug-related behavior in respondents who have been prescribed opioids for chronic pain. The full-length
form of the COMM consists of 17 items. Some individuals, especially compromised individuals, may be deterred
from taking the full questionnaire due to its length. This study examined the use of curtailment and stochastic
curtailment, two computer-based testing approaches that sequentially determine the test length for each
individual, to reduce the respondent burden of the COMM without compromising sensitivity and specificity.
Methods: Existing data from n = 415 participants, all of whom had taken the full-length COMM and had been
classified via the Aberrant Drug Behavior Index (ADBI), were divided into training (n = 214) and test (n = 201) sets.
Post-hoc analysis of the test set was performed to evaluate the screening results and test lengths that would have
been obtained, if curtailment or stochastic curtailment had been used. Sensitivity, specificity, and average test
length were calculated for each method and compared with the corresponding values of the full-length test.
Results: The full-length COMM had a sensitivity of 0.703 and a specificity of 0.701 for predicting the ADBI.
Curtailment reduced the average test length by 22% while maintaining the same sensitivity and specificity as the
full-length COMM. Stochastic curtailment reduced the average test length by as much as 59% while always
obtaining a sensitivity of at least 0.688 and a specificity of at least 0.701 for predicting the ADBI.
Conclusions: Curtailment and stochastic curtailment have the potential to achieve substantial reductions in
respondent burden without compromising sensitivity and specificity. The two sequential methods should be
considered for future computer-based administrations of the COMM.
Keywords: Substance abuse, Chronic pain, Opioids, Questionnaire, Respondent burden, Computer-based testingBackground
The continued presence of unrelieved pain as a serious
public health issue has been well-documented [1-4]. Opi-
oids have increasingly been used in recent years to address
the problem, and they may be an important component of
treatment for chronic pain [5]. However, some patients
who receive a prescription for opioids may be prone to
non-adherence or misuse behaviors, such as escalation of
their opioids, visiting multiple providers, or other overt
drug-seeking behaviors [6,7]. The identification of opioid* Correspondence: matthew.finkelman@tufts.edu
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reproduction in any medium, provided the ormisuse is thus critical in the treatment of chronic non-
cancer pain [7], but many physicians lack adequate train-
ing to make such an identification [8].
To assist clinicians in recognizing aberrant drug-related
behavior among respondents who have been prescribed
opioids, Butler et al. [7] introduced the Current Opioid
Misuse Measure (COMM), a 17-item self-report question-
naire. Because the COMM is designed to help assess
whether a given respondent is currently misusing opioids,
it should be distinguished from other instruments that
predict future misuse [9]. Previous research has validated
the COMM against the Aberrant Drug Behavior Index
(ADBI), a combination measure that incorporates in-
formation from a questionnaire taken by the patient, atral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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toxicology results. The COMM was found to exhibit
adequate sensitivity and specificity in both its original
validation study [7] and a cross-validation study using
a new population of patients [9].
Although most respondents can finish the full-length
COMM in a reasonable amount of time, some individuals
may be unable or unwilling to complete all 17 items.
Members of compromised subpopulations (e.g., those with
physical ailments and those who are at a low reading level)
are less likely to accept lengthy screeners [10]. The re-
sponse rate [11] and the quality of an individual’s answers
to a given questionnaire [12] may be improved by admin-
istering fewer items. Shortening an instrument may also
lessen the degree of stress associated with taking it and de-
crease the likelihood that respondents will drop out mid-
way through [13]. Finally, reducing respondent burden is
especially critical for lowering drop-out rates when a ques-
tionnaire is given to patients on multiple occasions over
time [13,14]—and such longitudinal tracking of patients
was listed as a goal of the COMM in its original validation
study [7]. These considerations demonstrate the need for
a version of the COMM that lessens respondent burden
while maintaining the sensitivity and specificity of the full-
length instrument.
A number of recent articles have shown that modern
advancements in computer-based testing can enhance
the efficiency of an assessment [15-17]. In particular,
computer-based forms have the potential to achieve the
same levels of sensitivity and specificity as their paper-
and-pencil counterparts, but by using fewer items on
average [18,19]. The reason for this advantage is that
computer-based forms can track a respondent’s answers
as the test progresses. By performing interim analysis of
these answers while assessment is underway, a computer
program can customize the test to the individual taking
it. A well-known component of this customization is the
use of sequential stopping rules to determine the appro-
priate test length for a given respondent. Two such stop-
ping rules that have been proposed for computer-based
testing are the methods of curtailment and stochastic
curtailment. As will be explained in the Methods sec-
tion, curtailment and stochastic curtailment attempt to
shorten each respondent’s questionnaire while main-
taining the same test outcome (“positive” or “negative”)
that would have been made if the full-length question-
naire had been used. In retrospective analyses of re-
sponses to the Medicare Health Outcomes Survey [18]
and the Center for Epidemiologic Studies-Depression
(CES-D) scale [19], both methods substantially reduced
the average number of items administered without com-
promising sensitivity and specificity. However, no previ-
ous study investigated either method as a means of
enhancing the efficiency of the COMM.The purpose of this study is twofold. First, we describe
how the stopping rules of curtailment and stochastic
curtailment can be applied to the COMM. Second, we
evaluate how successful these rules are in reducing re-
spondent burden and maintaining sensitivity and specifi-
city. For the latter objective, we conducted an analysis of
existing data from individuals who had already been ad-
ministered the full-length COMM and been classified
via the ADBI; thus, the research constitutes a “proof-of-
concept” study for using a computer-based COMM in
the future.
The article is organized as follows. The Methods sec-
tion describes how the data were collected, how the
COMM and ADBI are scored, how curtailment and sto-
chastic curtailment can be used in conjunction with the
COMM, and what analyses were performed. The Results
section presents sensitivity and specificity values, the
average test length of each method, and other statistics.
The Discussion and Conclusions sections explore the




This retrospective study used data from two sources: the
initial validation study and the cross-validation study of
the COMM. Details about the subjects who participated
in the initial validation study are provided in Butler et al.
[7]. Briefly, the sample consisted of 227 chronic non-
cancer pain patients from a hospital-based pain manage-
ment center in Massachusetts, a hospital-based pain
management center in Pennsylvania, and a private pain
management treatment center in Ohio. As reported in
Butler et al. [7], the mean (SD) age of participants was
50.8 (12.4) years, the mean (SD) number of years taking
opioids was 5.7 (9.2), the percentage of females was 62%,
and the percentage of Caucasians was 83%. Details about
the subjects who participated in the cross-validation
study are provided in Butler et al. [9]. Briefly, 226 non-
cancer pain patients from pain management centers in
five locations (Indiana, Massachusetts, New Hampshire,
Ohio, and Pennsylvania) comprised the study popula-
tion. As reported in Butler et al. [9], the mean (SD) age
of participants was 51.5 (13.8) years, the mean (SD) num-
ber of years taking opioids was 5.4 (5.8), the percentage
of females was 48%, and the percentage of Caucasians
was 87%. All subjects (from both the initial validation
study and the cross-validation study) were taking opioids
at the time the research was conducted. All subjects
signed an informed consent form. The Human Subjects
Committee of Inflexxion, Inc. approved the initial valid-
ation study; the Human Subjects Committee of the par-
ticipating clinical sites approved the cross-validation
study.
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In both the initial validation and cross-validation studies,
subjects were administered the COMM questionnaire.
The items making up this questionnaire are listed in
Table 1. Each item refers to the stem “In the past
30 days…” and has five possible answers: “never”
(scored 0), “seldom” (scored 1), “sometimes” (scored 2),
“often” (scored 3), and “very often” (scored 4). A respon-
dent’s total score is obtained by summing the individual
item scores; because there are 17 COMM items, scores on
the full-length test can range from 0 to 68. Butler et al.
[7] found that a cutoff score of ≥ 9 produced acceptable
sensitivity and specificity values.
In addition to taking the COMM, all participants were
subjected to assessment via the ADBI, which is described
in detail elsewhere [7,9]. As stated above, the ADBI is a
combination measure that includes information from
three sources. The first source of information is the Pre-
scription Drug Use Questionnaire (PDUQ), a 42-item
interview that evaluates pain condition, opioid use pat-
terns, social and family factors, family history of pain
and substance abuse syndromes, patient history of sub-
stance abuse, and psychiatric history [20]. To be consist-
ent with Compton et al.’s finding that respondents scoringTable 1 Descriptive statistics for the 17 items comprising the
Item (“In the past 30 days…”)
1. How often have you had trouble with thinking clearly or had
2. How often do people complain that you are not completing nece
things that need to be done, such as going to class, work, o
3. How often have you had to go to someone other than your pres
sufficient pain relief from your medications? (i.e. another doctor,
4. How often have you taken your medications differently from ho
5. How often have you seriously thought about hurting
6. How much of your time was spent thinking about opioid medicatio
them, dosing schedule, etc.)?
7. How often have you been in an argument
8. How often have you had trouble controlling your anger (e.g., road
9. How often have you needed to take pain medications belongi
10. How often have you been worried about how you’re handlin
11. How often have others been worried about how you’re handli
12. How often have you had to make an emergency phone call or sho
an appointment?
13. How often have you gotten angry with peop
14. How often have you had to take more of your medication
15. How often have you borrowed pain medication from s
16. How often have you used your pain medicine for symptoms other
you sleep, improve your mood, or relieve stres
17. How often have you had to visit the emergency
*IQR = Inter-quartile range.below 11 did not meet diagnostic criteria for a substance
use disorder [20], a score ≥ 11 was defined as a positive re-
sult for the PDUQ in the current study. The ADBI’s sec-
ond source of information is the Prescription Opioid
Therapy Questionnaire (POTQ), an 11-item measure of
opioid misuse that was adapted from the Physician Ques-
tionnaire of Aberrant Drug Behavior [6]. Each POTQ item
is rated dichotomously (“yes” or “no”) by the patient’s
treating physician; a positive answer to ≥ 2 items was
taken to be a positive result for the POTQ. Finally, the
ADBI’s third source of information is based on a urine
toxicology screen. As in previous research [7], the current
study defined a positive result as evidence of the subject
having taken an illicit substance or another opioid medica-
tion that had not been prescribed. Once the information
from each of the three sources had been collected, the re-
sults were pooled in order to obtain an overall classifica-
tion. Specifically, the overall classification for the ADBI
was defined as positive if (a) the result from the PDUQ
was positive or (b) the results from both the POTQ and
the urine toxicology screen were positive [9]. The ADBI
was used in the current study to assess the concurrent val-
idity of each method (curtailment, stochastic curtailment,













memory problems? 1.3 (1.1) 1.0 (2.0) 1.5 (1.2) 1.0 (2.0)
ssary tasks? (i.e., doing
r appointments)
0.8 (1.1) 0.0 (1.0) 0.8 (1.0) 0.0 (1.0)
cribing physician to get
the emergency room)
0.3 (0.7) 0.0 (0.0) 0.2 (0.6) 0.0 (0.0)
w they are prescribed? 0.6 (0.9) 0.0 (1.0) 0.6 (0.9) 0.0 (1.0)
yourself? 0.4 (0.8) 0.0 (1.0) 0.2 (0.6) 0.0 (0.0)
ns (having enough, taking 1.0 (1.0) 1.0 (1.0) 0.8 (1.0) 1.0 (1.0)
? 1.1 (0.9) 1.0 (1.0) 1.1 (1.0) 1.0 (2.0)
rage, screaming, etc.)? 0.7 (0.8) 1.0 (1.0) 0.8 (1.0) 0.0 (1.0)
ng to someone else? 0.1 (0.4) 0.0 (0.0) 0.0 (0.2) 0.0 (0.0)
g your medications? 0.5 (0.9) 0.0 (1.0) 0.4 (0.8) 0.0 (1.0)
ng your medications? 0.5 (0.9) 0.0 (1.0) 0.3 (0.7) 0.0 (0.0)
w up at the clinic without 0.2 (0.5) 0.0 (0.0) 0.1 (0.5) 0.0 (0.0)
le? 1.2 (0.8) 1.0 (1.0) 1.2 (1.0) 1.0 (2.0)
than prescribed? 0.6 (0.8) 0.0 (1.0) 0.5 (0.8) 0.0 (1.0)
omeone else? 0.1 (0.5) 0.0 (0.0) 0.0 (0.2) 0.0 (0.0)
than for pain (e.g. to help
s)?
0.2 (0.6) 0.0 (0.0) 0.2 (0.6) 0.0 (0.0)
room? 0.4 (0.7) 0.0 (1.0) 0.2 (0.5) 0.0 (0.0)
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in a later section.
Curtailment and stochastic curtailment of the COMM
As mentioned previously, curtailment and stochastic
curtailment rely on interim analysis of the respondent’s
answers while assessment is in progress. Both of these
methods thus require that the instrument be adminis-
tered via computer. Use of computer-based testing to
enhance the efficiency of questionnaires has been con-
sidered in numerous recent studies, due in part to the
importance of computerized assessments in the Patient-
Reported Outcomes Measurement Information System
(PROMIS) project [21-23]. We next describe how cur-
tailment and stochastic curtailment can be used in con-
junction with computer-based testing to improve the
efficiency of the COMM.
The fundamental idea of curtailment is to avoid ad-
ministering items that have no bearing on the respon-
dent’s final result from the questionnaire. By this logic,
an assessment should be stopped if presenting further
items will have no influence on the respondent’s final re-
sult. For example, suppose that a respondent is taking a
computer-based version of the COMM, and that the
cutoff value is ≥ 9 as suggested by Butler et al. [7]. Sup-
pose further that the respondent’s scores to the first
seven items are 1, 0, 2, 2, 1, 0, and 3, resulting in a cu-
mulative score of 9 (the sum of the seven item scores).
Because the respondent’s score has already reached the
cutoff value, he/she is guaranteed to be “screened in” by
the questionnaire (i.e., guaranteed to receive a positive
result from the COMM), regardless of his/her responses
to future items. A curtailment rule would observe this
fact, halt testing after the seventh item, and prescribe
that the respondent be “screened in,” thus eliminating
the respondent burden that would have resulted from
administering the final ten items. Conversely, consider a
second respondent who has a cumulative score of 4 after
taking the first 16 items. Regardless of the respondent’s
answer to the seventeenth and final item (which has a
maximum possible score of 4), he/she cannot possibly
reach the cutoff value of 9. A curtailment rule would ob-
serve this fact and halt testing after the sixteenth item,
prescribing that the respondent be “screened out” (i.e.,
that the respondent receive a negative result from the
COMM). Finally, consider a third respondent who has a
score of 0 after the first 15 items. Because this respond-
ent cannot reach the cutoff value of 9—even if he/she
receives a score of 4 on both the sixteenth item and
seventeenth item—a curtailment rule would halt testing
after the fifteenth item and prescribe that the respondent
be “screened out.”
To summarize the above, a curtailment rule halts test-
ing if (i) the respondent’s cumulative score reaches thecutoff value (in which case the respondent is “screened
in”) or (ii) the respondent’s cumulative score is low
enough that he/she cannot possibly reach the cutoff
value, regardless of his/her future answers (in which case
the respondent is “screened out”). The application of
these rules to the COMM will be referred to as the
COMM’s curtailed version. Because the curtailed version
always prescribes the same result (“screened in” or
“screened out”) as the full-length COMM, it also ex-
hibits the same sensitivity and specificity as the full-
length version. We note that administering the curtailed
version is straightforward if the COMM is given by com-
puter: the stopping rules of the curtailed version may be
written as a simple look-up table and programmed into
the computer for operational usage. An example of such
a look-up table will be presented in a later section.
Stochastic curtailment is similar in concept to curtail-
ment, but the former stops testing more liberally than the
latter. In addition to stopping when it is impossible for fu-
ture items to influence the final result of the question-
naire, stochastic curtailment also stops the test when
future items are unlikely to influence the final result. An-
other (equivalent) way of describing stochastic curtailment
is to state that the method stops testing when the prob-
ability of one of the possible outcomes (“screened in” or
“screened out”) reaches or exceeds a certain threshold,
given the respondent’s answers to the items administered
thus far. Previous studies [18,19] recommended setting
the threshold at 90%, 95%, or 99%.
To illustrate the above using a threshold of 95%, con-
sider a respondent who is taking the COMM via com-
puter and has completed the first five items of the
questionnaire. Suppose that based on the respondent’s
first five answers, his/her probability of receiving a
“screened in” result from the full-length COMM is esti-
mated to be at 89%; his/her probability of receiving a
“screened out” result is estimated at 11%. Because both
of these numbers are lower than 95%, stochastic curtail-
ment continues the assessment by administering another
item. Suppose next that based on the respondent’s an-
swer to the sixth item, his/her estimated probability of
receiving a “screened in” result rises to 97%; his/her
probability of receiving a “screened out” result falls to
only 3%. Because the 97% probability exceeds the 95%
threshold for stopping, stochastic curtailment halts the
questionnaire in favor of an immediate “screened in” re-
sult. If another respondent were to exhibit the reverse
probabilities after six items (3% for “screened in” and
97% for “screened out”), he/she would be given an im-
mediate “screened out” result. The application of such
rules to the COMM will be referred to as the COMM’s
stochastically curtailed version.
The most technical aspect of stochastic curtailment is
how to determine the above probabilities at each stage
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tionnaire where an interim analysis is performed, which
is typically after every item). Previous articles have
explained the estimation of these probabilities in detail
[18,19]. Briefly, the probabilities can be estimated and
used effectively as long as a training dataset of prior re-
spondents has been collected [18]. In other words, a pre-
requisite for stochastic curtailment to be used is that the
complete questionnaire (here, the 17-item COMM) be
administered to a group of initial respondents in a pilot
study. The results of the pilot study are compiled as the
training dataset, which is then used to estimate the
probabilities in question. Specifically, the probabilities
may be estimated by fitting a set of logistic regression
models, one for each stage of the questionnaire, to the
training dataset [19]. The logistic regression models are
then used to estimate a respondent’s chance of receiving
a “screened in” or “screened out” result, based on his/
her cumulative score at any given stage. Specifics of the
method can be found in Finkelman et al. [19], who also
examined a nonparametric approach to probability esti-
mation but found that logistic regression achieved a
greater reduction in respondent burden.
We note that it is not necessary to perform any cal-
culations of probabilities “in real time” as the respond-
ent is taking the assessment. Instead, all calculations
can be made in advance based on the data from the
pilot study. In particular, the results of the logistic re-
gression analyses can be used to determine which cu-
mulative scores would result in early stopping at each
stage of the questionnaire [19]. The stopping rules of
stochastic curtailment may then be written in a simple
look-up table that can be used for new respondents. An
example of such a table will be presented in a later sec-
tion; the table giving the stopping rules of stochastic
curtailment will be compared to the analogous look-up
table for curtailment.
Unlike curtailment, stochastic curtailment does not al-
ways produce the same result (“screened in” or “screened
out”) as the full-length version of a given questionnaire.
However, previous research found that when applied to
the CES-D, the method achieves acceptable concordance
with the full-length version of the instrument while sub-
stantially reducing the respondent burden [19]. The ques-
tion of whether similar results can be obtained for the
COMM will be addressed in a later section.
Although both curtailment and stochastic curtailment
are simple in concept, they have been studied rigorously
in the statistical literature. See Eisenberg and Ghosh [24]
and Eisenberg and Simons [25] for information about
the statistical properties of curtailment. See Davis and
Hardy [26] and Lan et al. [27] for information about ap-
plications of stochastic curtailment to clinical trials, as
well as theoretical results.Data analysis
The analysis involved data from the COMM’s initial val-
idation study and cross-validation study, both of which
were described in a previous section. Respondents who
had not completed the full-length COMM (i.e., who
were missing at least one of the 17 items) or had a missing
ADBI classification were excluded from the investigation.
The objective was to determine whether curtailment and
stochastic curtailment could reduce the respondent bur-
den of the COMM while maintaining the sensitivity and
specificity of the assessment. To this end, a retrospective
analysis was undertaken to determine the respondents’
test lengths and test outcomes (“screened in” or “screened
out”) that would have occurred if curtailment or stochastic
curtailment had been used. Such post-hoc simulation is
common when studying the efficiency of questionnaires
[14,18,19,21].
As explained previously, stochastic curtailment re-
quires the analysis of training data from an initial set of
respondents before the method can be used operation-
ally. To mimic the sequence of events as would occur in
practice, the logistic regression models utilized in sto-
chastic curtailment were first fitted to the dataset from
the COMM’s initial validation study. This dataset was
thus defined as the “training dataset” for the purpose of
the investigation. The results of the logistic regression
analysis were then used to find the stopping rules of sto-
chastic curtailment (i.e., to find the specific cumulative
COMM scores that would result in early stopping at
each stage of the test, and write them in look-up tables).
Three different probability thresholds—90%, 95%, and
99%–were examined, resulting in three separate sets of
stopping rules. These rules will hereafter be referred to
as SC-90, SC-95, and SC-99, respectively (“SC” standing
for “stochastic curtailment”). Evaluation of the different
stochastically curtailed versions was then performed on
the cross-validation dataset; that is, the test length and
test outcome that would have resulted from the SC-90,
SC-95, and SC-99 stopping rules were determined for
each respondent in the cross-validation dataset (here-
after referred to as the “test dataset”). The performance
of the full-length COMM and its curtailed version were
also evaluated using the same test dataset so that a stan-
dardized comparison could be made. In particular, for
each version of the questionnaire, the following statistics
were computed: sensitivity and specificity with respect
to the full-length COMM, sensitivity and specificity with
respect to the ADBI, average number of items adminis-
tered, standard deviation of the number of items adminis-
tered, and percentage of respondents whose tests stopped
early (i.e., prior to the seventeenth item). The last three of
these measures relate to respondent burden. Descriptive
statistics for each item (mean, standard deviation, median,
and inter-quartile range) were also calculated. All analyses
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(Version 2.11.1). We note that the partitioning of the data
into separate training and test datasets, as was done in our
analysis, is recommended in the statistical literature in lieu
of using the same dataset for both model fitting and per-
formance evaluation; the latter approach can result in mis-
leadingly positive results [28].
The Institutional Review Board at Tufts Medical Center
and Tufts University Health Sciences Campus granted
exempt status for this research project.
Results
Following the application of exclusion rules, the training
dataset had a final sample size of n = 214, while the test
dataset had a final sample size of n = 201. In the training
dataset, the mean (SD) COMM score was 10.1 (7.5); 104
respondents (48.6%) were “screened in” by the COMM
using a ≥ 9 cutoff, and 73 respondents (34.1%) were clas-
sified as positive by the ADBI. In the test dataset, the
mean (SD) COMM score was 8.9 (6.9); 86 respondents
(42.8%) were “screened in” by the COMM using a ≥ 9
cutoff, and 64 respondents (31.8%) were classified as
positive by the ADBI.
Table 1 presents descriptive statistics for each item of
the COMM. In both the training and test datasets, the
median value for every item was either 0 (“never”) or 1
(“seldom”). For 16 of the 17 items, the median in the












1 N/A N/A N/A N/A
2 N/A N/A N/A Score
3 N/A Score ≥ 9 N/A Score
4 N/A Score ≥ 9 N/A Score ≥
5 N/A Score ≥ 9 N/A Score ≥
6 N/A Score ≥ 9 N/A Score
7 N/A Score ≥ 9 Score = 0 Score
8 N/A Score ≥ 9 Score ≤ 1 Score
9 N/A Score ≥ 9 Score ≤ 1 Score
10 N/A Score ≥ 9 Score ≤ 2 Score
11 N/A Score ≥ 9 Score ≤ 3 Score
12 N/A Score ≥ 9 Score ≤ 3 Score
13 N/A Score ≥ 9 Score ≤ 4 Score
14 N/A Score ≥ 9 Score ≤ 5 Score
15 Score = 0 Score ≥ 9 Score ≤ 5 Score
16 Score ≤ 4 Score ≥ 9 Score ≤ 6 Score
17 Score ≤ 8 Score ≥ 9 Score ≤ 8 Score
*In the constrained version of stochastic curtailment, this stopping boundary is ≥ 9dataset; the lone exception was item 8 (“How often have
you had trouble controlling your anger (e.g., road rage,
screaming, etc.)?”), which had a median of 1 in the train-
ing dataset and a median of 0 in the test dataset. In both
datasets, the item with the highest mean was item 1
(“How often have you had trouble with thinking clearly
or had memory problems?”), which had a mean of 1.3 in
the training dataset and 1.5 in the test dataset. No item’s
mean in the training dataset was more than 0.2 from its
mean in the test dataset.
Table 2 presents stopping boundaries for each of the
sequential methods under study (curtailment, SC-99,
SC-95, and SC-90). That is, for each sequential method
examined herein, the table indicates the scores that result
in early stopping for each stage of the test. Scores that
produce a “screened out” result are labeled “Negative
stopping,” while scores that produce a “screened in” result
are labeled “Positive stopping.” For example, after 10 items
have been completed, curtailment never stops to produce
a “screened out” result (as denoted “N/A” in Table 2 to in-
dicate “Not Applicable”), but it stops to produce a
“screened in” result if the respondent’s score is ≥ 9 at that
stage. Continuing in the same row of the table, SC-99
stops after 10 items if the respondent’s score is ≤ 2
(“screened out”) or ≥ 9 (“screened in”); SC-95 stops if
the respondent’s score is ≤ 3 (“screened out”) or ≥ 8
(“screened in”); SC-90 stops if the respondent’s score












N/A N/A N/A Score = 4
= 8 N/A Score ≥ 6 N/A Score ≥ 5
≥ 9 N/A Score ≥ 7 N/A Score ≥ 6
8* N/A Score ≥ 7 Score = 0 Score ≥ 6
8* N/A Score ≥ 7 Score = 0 Score ≥ 6
≥ 9 Score = 0 Score ≥ 8 Score ≤ 1 Score ≥ 7
≥ 9 Score ≤ 2 Score ≥ 8 Score ≤ 2 Score ≥ 7
≥ 9 Score ≤ 3 Score ≥ 8 Score ≤ 3 Score ≥ 8
≥ 9 Score ≤ 3 Score ≥ 8 Score ≤ 3 Score ≥ 8
≥ 9 Score ≤ 3 Score ≥ 8 Score ≤ 4 Score ≥ 8
≥ 9 Score ≤ 4 Score ≥ 9 Score ≤ 4 Score ≥ 8
≥ 9 Score ≤ 4 Score ≥ 9 Score ≤ 4 Score ≥ 8
≥ 9 Score ≤ 5 Score ≥ 9 Score ≤ 6 Score ≥ 9
≥ 9 Score ≤ 6 Score ≥ 9 Score ≤ 6 Score ≥ 9
≥ 9 Score ≤ 6 Score ≥ 9 Score ≤ 7 Score ≥ 9
≥ 9 Score ≤ 6 Score ≥ 9 Score ≤ 7 Score ≥ 9
≥ 9 Score ≤ 8 Score ≥ 9 Score ≤ 8 Score ≥ 9
.
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the four (it has the largest range of scores that result in
early stopping), followed by SC-95, SC-99, and curtail-
ment (the most conservative stopping rule).
Most of the stopping boundaries in Table 2 are mono-
tonically nondecreasing: as the stage of the test advances,
the cutoff score required for early stopping generally
does not decrease. The one exception is SC-99, which
has a “Positive stopping” requirement of ≥ 9 at stage 3
but only a requirement of ≥ 8 at stages 4 and 5. This re-
sult may be surprising, as a score of 8 would intuitively
be considered less evidence of a final “screened in” result
at stage 4 or 5 than at stage 3. The result is possible,
however, because the stopping boundaries were obtained
by fitting a separate logistic regression model at each
stage of the questionnaire, without constraining these
boundaries to be monotonic. If monotonic boundaries
are preferred, a simple constrained version of stochastic
curtailment may be defined whereby the boundaries are
adjusted to be nondecreasing. To be conservative, the
stopping rule at stages 4 and 5 would be adjusted up-
ward to ≥ 9, as opposed to adjusting the stopping rule at
stage 3 downward to ≥ 8. The constrained boundaries
are noted in Table 2.
Table 3 presents the sensitivity and specificity values
of each method, as well as statistics related to respond-
ent burden. The full-length COMM had a sensitivity of
0.703 and a specificity of 0.701 for predicting the ADBI.
Curtailment and SC-99 always produced the same result
(“screened in” or “screened out”) as the full-length
COMM; hence, these methods had a sensitivity and spe-
cificity of 1 for predicting the full-length COMM, as well
as a sensitivity and specificity of 0.703 and 0.701, re-
spectively, for predicting the ADBI. SC-95 and SC-90
did not always match the result of the full-length
COMM, but their sensitivities for it were 0.977 and
0.965, respectively; their specificities for it were 1 and
0.991, respectively. Moreover, these methods exhibited
sensitivities of 0.688 or more, and specificities of 0.708
or more, for predicting the ADBI.
Regarding respondent burden, the full-length COMM,




Sensitivity Specificity Sensitivity Specifi
Full-length COMM 1 1 0.703 0.70
Curtailment 1 1 0.703 0.70
SC-99 1 1 0.703 0.70
SC-95 0.977 1 0.703 0.71
SC-90 0.965 0.991 0.688 0.70
*In the constrained version of stochastic curtailment, the SD of test length was 3.8therefore, its average (SD) test length was 17.0 (0.0), and
its percentage of respondents whose tests stopped early
was 0%. The average (SD) test lengths for curtailment,
SC-99, SC-95, and SC-90 were 13.3 (4.2), 10.7 (3.9), 8.7
(4.0), and 7.0 (4.2), respectively. The percentage of re-
spondents whose tests stopped early was at least 71.6%
for every sequential stopping method; the highest such
value was 96.5%, which was observed for SC-90.
We note that if the constrained version of SC-99 were
used, the results would be nearly identical to those of
SC-99. The two methods had the same sensitivity values,
specificity values, and percentages of respondents whose
tests stopped early. Their average test lengths were equal
to one decimal place. The standard deviation of test
lengths was 3.8 for the constrained SC-99, as opposed to
3.9 for SC-99.Discussion
There are many well-known benefits of computer-based
testing, including automated scoring, immediate data
entry, and facilitated tracking of change over time [29].
As described above, computer-based testing can also be
coupled with sequential stopping rules to reduce the re-
spondent burden of an assessment. Two such stopping
rules, both of which enhanced the efficiency of the Medi-
care Health Outcomes Survey [18] and the CES-D [19] in
previous post-hoc simulations, are curtailment and sto-
chastic curtailment. However, prior to the current study,
neither of these stopping rules had been investigated for
use with the COMM.
Results of the study indicated that both curtailment
and stochastic curtailment have the potential to reduce
the respondent burden of the COMM without comprom-
ising sensitivity and specificity. Curtailment lowered the
average test length by 22% while maintaining the same
sensitivity and specificity as the full-length COMM. SC-99
also maintained sensitivity and specificity values identical
to those of the full-length COMM while reducing the
average test length by 37%. The sensitivities and specific-
ities of SC-95 and SC-90 for predicting the ADBI were
within 1.5% of those of the full-length COMM, while theseh method (based on the test dataset: n = 201)
BI Average test length SD of test length % of test lengths < 17
city
1 17.0 0.0 0.0
1 13.3 4.2 71.6
1 10.7 3.9* 88.1
5 8.7 4.0 90.0
8 7.0 4.2 96.5
for SC-99.
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respectively.
Which sequential stopping rule to use operationally
will depend on the practitioner’s desired level of con-
cordance with the full-length COMM. If the practitioner
requires that the result of the shortened version
(“screened in” or “screened out”) match that of the full-
length version for all respondents, then curtailment is
the correct method to use. We note that the result of
SC-99 also matched that of the full-length COMM for
every respondent considered in the current study; how-
ever, due to its stochastic nature (and unlike curtail-
ment), SC-99 is not guaranteed to match the full-length
COMM for 100% of future respondents. If the practi-
tioner is willing to accept a possible decrement in sensi-
tivity and/or specificity to achieve a greater reduction in
respondent burden, then the more aggressive SC-99 may
be preferred to curtailment. Further gains in average test
length can be achieved by using the more liberal SC-95
or SC-90, although these methods may also exhibit less
concordance with the result of the full-length COMM.
While the methods examined herein produced substan-
tial improvements in efficiency, these improvements could
potentially be enhanced by considering the ordering of the
COMM items. The current article assumed that items
would be presented in the same order that they are given
in the paper-and-pencil version of the COMM. This as-
sumption was made to promote comparability between
the computerized and paper-and-pencil versions. How-
ever, it ignores the possibility that in a computerized ver-
sion of the COMM, items could be judiciously ordered to
augment the gains made by curtailment and stochastic
curtailment. Previous research [30] has shown that by pre-
senting the most informative items (e.g., the items selected
first by a stepwise logistic regression procedure) at the be-
ginning of the test, the average test lengths of curtailed
and stochastically curtailed assessments are reduced with-
out loss of classification accuracy. Future research should
investigate the impact of item ordering in a computer-
based COMM.
Another mechanism by which the COMM’s statistical
properties could potentially be improved is the use of a
more sophisticated classification model. The simple ≥ 9
cutoff rule is desirable from the standpoints of interpret-
ability and logistical ease, but more rigorous statistical
classification tools might achieve better sensitivity and
specificity. Curtailment and stochastic curtailment have
previously been studied alongside a multiple logistic re-
gression classification rule [18,30]; such a rule has the
added benefit of facilitating the inclusion of demo-
graphic information in the model if desired. Addition-
ally, the classification of respondents via Item Response
Theory (IRT) and computerized adaptive testing (CAT),
which would allow the item ordering to be individualizedat the respondent level, could be explored. Although the
suitability of IRT and CAT for application to the COMM
has not yet been examined, a comparison between the
curtailed, stochastically curtailed, and CAT-based versions
of the COMM could be illuminating. Previous compari-
sons using the CES-D suggested that stochastic curtail-
ment can achieve reductions in test length similar to those
of CAT while exhibiting greater concordance with the
classifications of the full-length instrument [19].
Regarding limitations of the current study, one was its
retrospective nature: responses were analyzed post-hoc
rather than collecting data prospectively. However, such
post-hoc simulation to establish a “proof-of-concept” is a
typical first step in evaluating potential computer-based
testing procedures [14,18,19,21]. A second limitation was
the sample size of the study, which was smaller than the
sample sizes of previous applications of curtailment and
stochastic curtailment [18,19]. However, the fact that
the stopping rules were successful when applied to the
test dataset, despite having been trained on a relatively
modest-sized training dataset, suggests the robustness
of the methodology. Third, the methods were evaluated
using only one test dataset, limiting the generalizability
of the results. We further caution readers that while the
look-up table for curtailment (Table 2) is applicable to
any population for which a ≥ 9 cutoff is appropriate, the
look-up tables for SC-99, SC-95, and SC-90 (also shown
in Table 2) are sample-specific and may not be suitable
for other populations. Therefore, before stochastic cur-
tailment is used for a different population of respon-
dents, new look-up tables should be calculated based on
pilot data from that population. See Finkelman et al.
[19] for a thorough description of how to calculate such
look-up tables.
It should be reiterated that at 17 items, the full-length
COMM is not unduly time-consuming for many individ-
uals who take it. Nevertheless, reducing the respondent
burden of an assessment can result in benefits such as
an enhanced response rate [11], including among mem-
bers of compromised subgroups [10]. Other potential
advantages of shortening an instrument are an improve-
ment in the quality of answers obtained [12], a reduction
in respondents’ stress levels [13], and a lower drop-out
rate [13]. Alleviating the respondent burden may be par-
ticularly important for the COMM, given that this ques-
tionnaire was designed to be administered on multiple
occasions to track patient status over time [7].
We also emphasize that the COMM was not designed
as a standalone mechanism for classification. Rather, it
was developed as a screening tool to help clinicians in
their assessment of risk for opioid misuse [7,9]. There-
fore, the curtailed and stochastically curtailed versions
should also be regarded as aids to clinicians, rather than
as standalone classification tools.
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this study’s results in different populations. In addition
to retrospective analyses, curtailment and stochastic cur-
tailment should be pilot-tested in live computer-based
administrations. Subjects from compromised subpopula-
tions, such as those with physical ailments and those who
are at a low reading level, should be included in the pilot
testing, considering that these subpopulations are most
likely to benefit from reduced test lengths [10]. The results
of the live tests should be compared to the results of post-
hoc simulation. All of these steps will be undertaken in fu-
ture work.Conclusions
Within the limitations of the study, results suggest that
curtailment and stochastic curtailment reduce the re-
spondent burden of the COMM without compromising
its sensitivity and specificity. Therefore, these sequential
methods have the potential to improve the COMM’s re-
sponse rate and enhance the quality of its respondents’
answers, particularly among members of compromised
subpopulations. Curtailment and stochastic curtailment
should be considered for future computer-based admin-
istrations of the COMM.Abbreviations
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